Penumbra

Penumbra

World Rank (Jan-05-2024)
1,813
Market Cap (Jan-05-2024)
8.942 Billion USD
World Rank (Jul-30-2023)
1,468
Market Cap (Jul-30-2023)
11.784 Billion USD
World Rank (Jan-07-2022)
1,967
Market Cap (Jan-07-2022)
9.508 Billion USD
World Rank (Jan-01-2021)
2,441
Market Cap (Jan-01-2021)
6.354 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 553
Headquarters Country
USA
Nasdaq / NYSE Code
PEN
Market Cap (Mar-08-2026)
13.29
Employee Count
3,900
Employee Count as of Date
As on 2022
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
847 Million USD
Annual Operating Income in USD
6 Million USD
Annual Net Income in USD
-2 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,370 Million USD
Total Liabilities in USD
372 Million USD
Total Equity in USD
998 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Medical Equipment / Instruments
HealthCare Products
Company Website
PENUMBRA INC
Yahoo
Yahoo @ NYSE
Company Profile

Penumbra is a Healthcare company. It designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. The headquarters is in USA.

Annual Results Summary

PENUMBRA - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueGross IncomeOperating IncomeNet Income
Dec-20228475356-2 (Loss)
Dec-2021747475-7 (Loss)5
Dec-2020560338-38 (Loss)-15 (Loss)
Dec-20195473714748
Dec-2018444292296
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,370 Million USD.

Total Liabilities as on Dec-2022 was 372 Million USD.

Total Equity as on Dec-2022 was 998 Million USD.

Founded Year
2004
IPO Year
2015
Stock Exchange
NYSE
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Medical/Dental Instruments

Share